Novel suturelesss scleral IOL fixation technique successful

Article

A novel sutureless scleral IOL fixation technique is successful in patients with insufficient posterior capsule support.

A novel sutureless scleral IOL fixation technique is successful in patients with insufficient posterior capsule support, proves a study in the journal Eye.

Dr Y. Totan et al., Department of Ophthalmology, Fatih University, Medical School, Emek, Turkey, included eight eyes of seven patients in the study. Scleral tunnels were prepared by inserting a 25 G transconjunctival sutureless vitrectomy (TSV) microcannulas using the trocars.

Anterior vitrectomy was completed via the clear corneal paracentesis with an anterior chamber maintainer (ACM). Then the three-piece foldable IOL haptics were incarcerated into the scleral tunnels.

There were no complications recorded such as postoperative endophthalmitis, glaucoma, IOL tilt/decentralization and retinal detachment. There was less incidence of surgical-induced astigmatism because the foldable IOL was injected through a clear corneal incision.

Although the procedure could cause minimal trauma, it also provides good IOL stabilization, a decrease in IOL tilt, shorter operation time and postoperative quiet eye.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.